Share-Based Compensation (Tables)

12 Months Ended

Jun. 30, 2018

Share-based Compensation

Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

	June 30, 2018			June 30, 2017			June 30, 2016
Risk-free interest rate	2.1		%	1.1		%	1.7		%
Expected volatility	57.6		%	55.6		%	48.3		%
Expected dividend yield	—			—			—
Forfeiture rate	6.5		%	6.5		%	6.5		%
Expected term	5.4 years			5.2 years			5.2 years
Weighted average fair value	$	11.25		$	15.33		$	26.24

Summary of stock option award activity

							Weighted
			Weighted-				Average
			Average		Aggregate		Remaining
			Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards		Price		Value		Life (yrs.)
Outstanding at June 30, 2015	1,975		$	15.39	$	86,983	7.2
Granted	58		59.20
Exercised	(254	)	12.62		$	6,168
Forfeited, expired or repurchased	(49	)	32.66
Outstanding at June 30, 2016	1,730		$	16.77	$	19,524	6.3
Granted	11		31.30
Exercised	(234	)	7.38		$	4,849
Forfeited, expired or repurchased	(32	)	33.04
Outstanding at June 30, 2017	1,475		$	18.02	$	12,212	5.7
Granted	50		21.43
Exercised	(445	)	7.23		$	4,243
Forfeited, expired or repurchased	(23	)	30.83
Outstanding at June 30, 2018	1,057		$	22.46	$	2,584	5.4
Vested and expected to vest at June 30, 2018	1,053		$	22.46	$	2,584	5.4
Exercisable at June 30, 2018	1,006		$	22.25	$	2,584	5.2

Summary of nonvested restricted stock awards

(In thousands)	Awards		Weighted Average Grant - date Fair Value		Aggregate Intrinsic Value
Non-vested at June 30, 2015	98		$	37.83
Granted	147		54.64
Vested	(66	)	47.11		$	3,511
Forfeited	(12	)	47.67
Non-vested at June 30, 2016	167		$	48.22
Granted	298		24.73
Vested	(86	)	42.60		$	2,564
Forfeited	(45	)	32.90
Non-vested at June 30, 2017	334		$	30.71
Granted	641		18.01
Vested	(191	)	31.30		$	4,104
Forfeited	(80	)	20.95
Non-vested at June 30, 2018	704		$	20.06

Schedule of nonvested performance-based shares

(In thousands, except for weighted average price and life data)	Awards		Weighted Average Grant - date Fair Value		Aggregate Intrinsic Value
Non-vested at June 30, 2017	—		$	—
Granted	47		$	25.58
Vested	(27	)	$	25.58	$	574
Forfeited	—		$	—
Non-vested at June 30, 2018	20		$	25.58

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

	For Fiscal Year Ended June 30,
(In thousands)	2018		2017		2016
Selling, general and administrative expenses	$	7,570	$	5,855	$	9,529
Research and development expenses	680		661		760
Cost of sales	1,646		1,203		1,273
Total	$	9,896	$	7,719	$	11,562
Tax benefit at statutory rate	$	2,919	$	2,818	$	4,220